China's leading auto insurance technology platform, today announced that its Founder, Chief Executive Officer and Chairman, Lei Zhang, recently purchased Class A ordinary shares of Cheche in the open ...

New U.S. patent issued covering the identification of a novel biomarker of coronavirus pneumonia (=60% fraction of inspired oxygen (FiO2)) prognostic for potential opaganib efficacy in treating ...

Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that navenibart (STAR-0215) ...

PORTLAND, Tenn., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. (“Shoals”), a global leader in electrical balance of system (“EBOS”) solutions for the energy transition market, ...

MBX 2109 is an investigational, PTH peptide prodrug designed as a once-weekly PTH replacement therapy with the potential to normalize serum calcium levels, reduce the need for active vitamin D and ...

Of the 52 million adults in the U.S. that own crypto, about 6.5 million live in seven ... a tense relationship with the industry due in part to frustrations with Securities and Exchange Commission ...

AT&T purchased DirecTV for $48.5 billion back in 2015. But in 2021, following the loss of millions of customers, AT&T sold a ...

Will Zhang, Chairman and CEO of Antelope Enterprise, commented,“The revenue for the livestreaming ecommerce business segment came in at $43.4 million for the first six months of 2024, modestly lower ...

(North Dakota Monitor) -A North Dakota rancher and a partner are poised to pay about $15.7 million for a beef marketing ...

Biohaven initiated a pivotal Phase 2 trial evaluating BHV-2100 in the acute treatment of migraineBHV-2100 is a potential first-in-class, potent, orally administered Transient Receptor Potential ...

KC-46A New Hampshire-based KC-46A aircrew refuel a U.S. Navy F/A-18F Super Hornet off the coast of Maryland on July 1, 2020.

BioStem Technologies, Inc. (OTC: BSEM) (“BioStem” or the “Company”), a leading MedTech company focused on the development, manufacture and commercialization of placental-derived biologics, announces ...